Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension

Respiration

Volumn 76, Issue 2, 2008, Pages 154-159

  Krug, Sabine ^a   Hammerschmidt, Stefan ^a   Pankau, Hans ^a   Wirtz, Hubert ^a   Seyfarth, Hans Jürgen ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chronic thromboembolic pulmonary hypertension; Iloprost; Pulmonary endarterectomy

Indexed keywords

BOSENTAN; ILOPROST; SILDENAFIL;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENDARTERECTOMY; FEMALE; HEART CATHETERIZATION; HEART OUTPUT; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; OXYGEN TENSION; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SINGLE DRUG DOSE;

ADMINISTRATION, INHALATION; ADULT; AGED; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 49949112962     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107977     Document Type: Article

References (33)

1. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264.
2. Lang IM: Chronic thromboembolic pulmonary hypertension - not so rare after all. N Engl J Med 2004;350:2236-2238.
3. Fedullo PF, Auger WR, Kerr KM, Rubin LJ: Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-1472.
4. Moser KM, Bloor CM: Pulmary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993;103:685-692.
5. Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J: Surgical treatments/interventions for pulmonary arterial hypertension. ACCP evidence-based clinical practice guidelines. Chest 2004;126:63S-71S.
6. Riedel M, Stanek V, Widimsky J, Prerovsky I: Longterm follow-up of patients with pulmonary thromboembolism. Chest 1982;81:151-158.
7. Lewczuk J, Piszko P, Jagas J, Porada A, Wojciak S, Sobkowicz B, Wrabec K: Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001;119:818-823.
8. Ono F, Nagaya N, Okumura H, Shimizu Y, Kyotani S, Nakanishi N, Miyatake K: Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003;123:1583-1588.
9. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT: Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-349.
10. Seyfarth HJ, Hammerschmidt S, Gessner C, Halank M, Wirtz H: Chronic thromboembolic pulmonary hypertension - therapeutic options. Curr Respir Med Rev 2006;2:431-438.
11. Hughes RJ, Jais X, Bonderman D, Suntharalingam J, Humbert M, Lang I, Simonneau G, Pepke-Zaba J: The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension. A 1-year follow-up study. Eur Respir J 2006;28:138-143.
12. Hoeper MM, Kramm T, Wilkens H, Schulze C, Schafers HJ, Welte T, Mayer E: Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2363-2367.
13. Hughes R, George P, Parameshwar J, Cafferty F, Dunning J, Morrell NW, Pepke-Zaba J: Bosentan in inoperable chronic thromboembolic pulmonary hypertension. Thorax 2005;60:707.
14. Bonderman D, Nowotny R, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Klepetko W, Lang IM: Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2599-2603.
15. Seyfarth HJ, Hammerschmidt S, Pankau H, Winkler J, Wirtz H: Long-term bosentan in chronic thromboembolic pulmonary hypertension. Respiration 2006;569:1-6.
16. Ghofrani HA, Schermuly RT, Rose F, Wiedemann R, Kohstall MG, Kreckel A, Olschewski H, Weissmann N, Enke B, Ghofrani S, Seeger W, Grimminger F: Sildenafil for longterm treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003;167:1139-1141.
17. Seyfarth HJ, Pankau H, Hammerschmidt S, Schauer J, Wirtz H, Winkler J: Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy. Chest 2005;128:709-713.
18. Nagaya N, Shimizu Y, Satoh T, Oya H, Uematsu M, Kyotani S, Sakamaki F, Sato N, Nakanishi N, Miyatake K: Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart 2002;87:340-345.
19. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N: Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-343.
20. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ: Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:595-600.
21. Scelsi L, Ghio S, Campana C, D'Armini AM, Serio A, Klersy C, Piovella F, Vigano M, Tavazzi L: Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions. Ital Heart J 2004;5:618-623.
22. Lang I, Gomez-Sanchez M, Kneussl M, Naeije R, Escribano P, Skoro-Sajer N, Vachiery JL: Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest 2006;129:1636-1643.
23. Olschewski H, Simonneau G, GalièN, et al: Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-329.
24. Fishman AP: Clinical classification of pulmonary hypertension. Clin Chest Med 2001;22:385-391.
25. Kramm T, Eberle B, Guth S, Mayer E: Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005;28:882-888.
26. Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E: Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003;76:711-718.
27. Webb SA, Stott S, van Heerden PV: The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intensive Care Med 1996;22:353-355.
28. Roig Figueroa V, Herrero Pérez A, de la Torre Ferrera N, Hernandez Garcia E, Aller Alvarez JL, Para Cabello J: Iloprost for chronic thromboembolic pulmonary hypertension. Arch Bronconeumol 2004;40:326-328.
29. Ulrich S, Fischler M, Speich R, Popov V, Maggiorini M: Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest 2006;130:841-846.
30. Ganz W, Donoso R, Marcus HS, Forrester JS, Swan HJC: New technique for measurement of cardiac output by thermodilution in man. Am J Cardiol 1971;27:392-399.
31. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN: Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res 2000;26:287-301.
32. Olschewski H, Hoeper MM, Borst MM, Ewert R, Grunig E, Kleber FX, Kopp B, Opitz C, Reichenberger F, Schmeisser A, Schranz D, Schulze-Neick I, Wilkens H, Winkler J, Worth H: Diagnosis and therapy of chronic pulmonary hypertension. Pneumologie 2006;60:749-771.
33. Olschewski H, Rohde B, Behr J, Ewert R, Gessler T, Ghofrani HA, Schmehl T: Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. Chest 2003;124:1294-1304.